Sigma-Aldrich downgraded to Neutral from Overweight at JPMorgan JPMorgan downgraded Sigma-Aldrich and other Life Sciences & Diagnostics names ahead of the Q2 reporting season. The firm keeps a $75 price target for shares.
News For SIAL From The Last 14 Days
Check below for free stories on SIAL the last two weeks.